Preservatives in artificial tears: Assessing impact on dry eye symptoms
Acta Ophthalmologica · 2025-11 · 103 (7) · 823-830
DOI: 10.1111/aos.17500 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Ophthalmologica, online erschienen am 22.04.2025. Verfasst von Astrid Dissing Sjö und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Lubricant Eye Drops, Preservatives, Pharmaceutical. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Synoptik-Fonden, Velux Fonden, Asta & Jul. P. Justesens Fond.
Abstract (Originalsprache)
Purpose
To examine the association between the presence of dry eye disease ( DED ) symptoms when using BAK ‐preserved artificial tears ( AT ) compared to preservative‐free AT .
Methods
In this cross‐sectional study, we used data collected as part of Project ‘Finding Ophthalmic Risk and Evaluating the Value of Eye exams and their predictive Reliability’ ( FOREVER ). To analyse the strength and direction of associations, we used binomial logistic regression models adjusted for age, sex, smoking and eye diseases. The analysis was conducted on responses regarding AT formulations and seven distinct DED symptoms from 67 951 participants in Project FOREVER , including 8039 AT users.
Results
Our analysis showed statistically significant higher odds ratios ( ORs ) of experiencing itching and blurred vision among users of BAK ‐preserved AT compared to preservative‐free AT users, with ORs of 1.26 (95% CI 1.01–1.58) and 1.28 (95% CI 1.02–1.60), respectively. Additionally, a borderline significant trend indicated an increased number of DED symptoms in the BAK ‐preserved AT group compared to preservative‐free AT users. Furthermore, our study provided a comprehensive overview of AT usage patterns within the cohort, illustrating the proportion of users for each type of AT .
Conclusion
Our findings suggest that BAK ‐preserved AT may worsen DED symptoms. We found higher ORs for experiencing itching and blurred vision as well as a tendency towards experiencing a higher number of symptoms when using BAK ‐preserved AT compared to preservative‐free AT . Further longitudinal studies with additional questions on AT usage and clinical assessments are needed to validate these findings and optimize AT formulations for safer, effective DED management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
- Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Astrid Dissing Sjö, Jens Rovelt, Miriam Kolko
Förderung
- Synoptik-Fonden
- Velux Fonden
- Asta & Jul. P. Justesens Fond
- A.P. Møller Fonden
- Mauritzen La Fontaine Familiefond
- Danish Life Science Cluster
- A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal
Zitieren
APA
Sjö, A. D., Rovelt, J., Ahrenberg, S., & Kolko, M. (2025). Preservatives in artificial tears: Assessing impact on dry eye symptoms. Acta Ophthalmologica, 103(7), 823-830. https://doi.org/10.1111/aos.17500
Vancouver
Sjö AD, Rovelt J, Ahrenberg S, Kolko M. Preservatives in artificial tears: Assessing impact on dry eye symptoms. Acta Ophthalmologica. 2025;103(7):823-830. doi:10.1111/aos.17500
BibTeX
@article{Sj2025,
author = {Sjö, Astrid Dissing and Rovelt, Jens and Ahrenberg, Simone and Kolko, Miriam},
title = {Preservatives in artificial tears: Assessing impact on dry eye symptoms},
journal = {Acta Ophthalmologica},
year = {2025},
volume = {103},
number = {7},
pages = {823--830},
doi = {10.1111/aos.17500}
}
EUVIMED